Hormonal GHRH, somatostatin, or ghrelin dysregulation have been suggested as the neuroendocrine changes that underlie decreased plasma GH levels in obesity [15,16]. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.